Its obvious to everyone following the markets that since the Fed rate cut, China stocks are red hot. Contributing factors include China’s robust economy, the weak US dollar, and a typical wave of stock trading momentum …. anything with a China story is running hot.
In case you’re thinking “how do I find a little China stock that isn’t horribly overpriced, that actually has a strong balance sheet, real income and earnings, and hasn’t been discovered yet?”
Take at look at China Medical Corporation
This little company actually has a reliable income stream from selling generic medicines in China. They distribute over 2,200 products. But they also hold some enticing technology in the area of aflatoxins.
Aflatoxins are fungi — molds that affect grains. They are considered to be carcinogenic to humans and livestock. Grains stored in hot humid conditions or grown in drought conditions are vulnerable to aflatoxin growth. For example, the FDA has restrictions on corn with more than 20 parts-per-billion.
With large increases in inventory placed in its distribution pipeline, these numbers could be poised for a very significant bump in upcoming quarters.
Impressive and stable economic base, with some cutting edge technologies poised to meet a huge market opportunity, this is one little China stock with a lot going for it. Definitely one to add to your basket and keep on radar.
/wp-content/uploads/2017/05/CitronLogo2017-350x65-1.png00Citron Research/wp-content/uploads/2017/05/CitronLogo2017-350x65-1.pngCitron Research2007-10-03 10:11:352017-05-30 04:00:22Citron Covers China Medical Corporation (OTC:CHME)